USD 22.45
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| LWAY | 0.3 | 0.7 | -4.6 | -15.0 | 83.1 | 59.4 | 336.8 | 805.2 | 21.9 | 4390 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | LWAY |
| name | Lifeway Foods, Inc. |
| price | 22.45 |
| changes percentage | 0.268 |
| change | 0.06 |
| day low | 22.13 |
| day high | 22.94 |
| year high | 28.61 |
| year low | 9.93 |
| market cap | 332630425 |
| price avg 50 | 23.883 |
| price avg 200 | 20.1206 |
| exchange | NASDAQ |
| volume | 52809 |
| avg volume | 87516 |
| open | 22.61 |
| previous close | 22.39 |
| eps | 0.86 |
| pe | 26.1 |
| earnings announcement | 2025-03-18T10:00:00.000+0000 |
| shares outstanding | 14816500 |
| timestamp | 2025-01-17 21:00:01 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000814586 | |||
| revenue | 160123000 | 141568000 | 13.11 |
| gross profit | 42441000 | 26786000 | 58.44 |
| gross profit ratio | 0.27 | 0.19 | 40.08 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 25446000 | 24437000 | 4.13 |
| interest income | 0 | 267000 | -100.00 |
| interest expense | 384000 | 267000 | 43.82 |
| ebitda | 20195000 | 5080000 | 297.54 |
| ebitdaratio | 0.13 | 0.04 | 235.55 |
| operating income | 16995000 | 2349000 | 623.50 |
| operating income ratio | 0.11 | 0.02 | 539.66 |
| net income | 11367000 | 924000 | 1130.19 |
| net income ratio | 0.07 | 0.01 | 987.64 |
| eps | 0.78 | 0.06 | 1200.00 |
Revenue Growth: revenue increased to 160 million in 2023 from 142 million in 2022 representing a change of 13.11%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 42 million in 2023 from 27 million in 2022 representing a change of 58.44%. This indicates a sales profitability growth, which is a positive sign for the company.
Earnings per Share (EPS): EPS increased to 0.78 in 2023 from 0.78 in 2022 representing a change of 1200.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 25 million in 2023 from 24 million in 2022 representing a change of 4.13%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 20 million in 2023 from 5 million in 2022 representing a change of 297.54%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 17 million in 2023 from 2 million in 2022 representing a change of 623.5%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 11 million in 2023 from 1 million in 2022 representing a change of 1130.19%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000814586 | |||
| revenue | 46095000 | 49157000 | -6.23 |
| gross profit | 11867000 | 13140000 | -9.69 |
| gross profit ratio | 0.26 | 0.27 | -3.69 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 7678000 | 7754000 | -0.98 |
| interest income | 0 | 0 | NaN |
| interest expense | 4000 | 47000 | -91.49 |
| ebitda | 5185000 | 6242000 | -16.93 |
| ebitdaratio | 0.11 | 0.13 | -11.42 |
| operating income | 4189000 | 5386000 | -22.22 |
| operating income ratio | 0.09 | 0.11 | -17.06 |
| net income | 2976000 | 3783000 | -21.33 |
| net income ratio | 0.06 | 0.08 | -16.11 |
| eps | 0.2 | 0.26 | -23.08 |
Revenue Growth: revenue decreased to 46 million in 2024Q3 from 49 million in 2024Q2 representing a change of -6.23%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to 12 million in 2024Q3 from 13 million in 2024Q2 representing a change of -9.69%. This indicates a sales profitability decline, which is a negative sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 5 million in 2024Q3 from 6 million in 2024Q2 representing a change of -16.93%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 4 million in 2024Q3 from 5 million in 2024Q2 representing a change of -22.22%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 3 million in 2024Q3 from 4 million in 2024Q2 representing a change of -21.33%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.2 in 2024Q3 from 0.2 in 2024Q2 representing a change of -23.08%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Expenses: Operating Expenses decreased to 8 million in 2024Q3 from 8 million in 2024Q2 representing a change of -0.98%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000814586 | |||
| total assets | 81654000 | 68999000 | 18.34 |
| total liabilities | 21218000 | 21429000 | -0.98 |
| total equity | 60436000 | 47570000 | 27.05 |
| cash and cash equivalents | 13198000 | 4444000 | 196.98 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 1800000 | -100.00 |
| total current assets | 38196000 | 26978000 | 41.58 |
| total non current assets | 43458000 | 42021000 | 3.42 |
| total current liabilities | 16616000 | 13042000 | 27.40 |
| total non current liabilities | 4602000 | 8387000 | -45.13 |
| common stock | 6509000 | 6509000 | 0.00 |
| retained earnings | 65797000 | 54430000 | 20.88 |
| total debt | 2925000 | 6678000 | -56.20 |
Total Assets: Total Assets increased to 82 million in 2023 from 69 million in 2022 representing a change of 18.34%. Suggesting a growth in asset holdings.
Total Liabilities: Total Liabilities decreased to 21 million in 2023 from 21 million in 2022 representing a change of -0.98%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 60 million in 2023 from 48 million in 2022 representing a change of 27.05%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 13 million in 2023 from 4 million in 2022 representing a change of 196.98%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 38 million in 2023 from 27 million in 2022 representing a change of 41.58%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 66 million in 2023 from 54 million in 2022 representing a change of 20.88%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 3 million in 2023 from 7 million in 2022 representing a change of -56.2%. This indicates a reduction in overall debt burden.
Total Current Liabilities: Total Current Liabilities increased to 17 million in 2023 from 13 million in 2022 representing a change of 27.4%. This indicates a higher short-term debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000814586 | |||
| total assets | 91309000 | 84943000 | 7.49 |
| total liabilities | 19786000 | 16946000 | 16.76 |
| total equity | 71523000 | 67997000 | 5.19 |
| cash and cash equivalents | 20558000 | 14633000 | 40.49 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 0 | NaN |
| total current assets | 44766000 | 39281000 | 13.96 |
| total non current assets | 46543000 | 45662000 | 1.93 |
| total current liabilities | 16706000 | 13857000 | 20.56 |
| total non current liabilities | 3080000 | 3089000 | -0.29 |
| common stock | 6509000 | 6509000 | 0.00 |
| retained earnings | 74982000 | 72006000 | 4.13 |
| total debt | 136000 | 154000 | -11.69 |
Total Assets: Total Assets increased to 91 million in 2024Q3 from 85 million in 2024Q2 representing a change of 7.49%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 72 million in 2024Q3 from 68 million in 2024Q2 representing a change of 5.19%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 21 million in 2024Q3 from 15 million in 2024Q2 representing a change of 40.49%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 45 million in 2024Q3 from 39 million in 2024Q2 representing a change of 13.96%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 75 million in 2024Q3 from 72 million in 2024Q2 representing a change of 4.13%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of -11.69%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 20 million in 2024Q3 from 17 million in 2024Q2 representing a change of 16.76%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 17 million in 2024Q3 from 14 million in 2024Q2 representing a change of 20.56%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000814586 | |||
| net change in cash | 8754000 | -4789000 | 282.79 |
| operating cash flow | 16941000 | 3987000 | 324.91 |
| free cash flow | 12590000 | 538000 | 2240.15 |
| capital expenditure | -4351000 | -3449000 | -26.15 |
| depreciation and amortization | 3162000 | 2972000 | 6.39 |
| deferred income tax | -28000 | -172000 | 83.72 |
| stock based compensation | 1497000 | 1109000 | 34.99 |
| accounts payables | 1859000 | 1945000 | -4.42 |
| inventory | 527000 | -1345000 | 139.18 |
| acquisitions net | 0 | -580000 | 100.00 |
| investments in property plant and equipment | -4351000 | -3449000 | -26.15 |
| net cash used for investing activites | -4410000 | -4029000 | -9.46 |
| debt repayment | -3777000 | -750000 | -403.60 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | -3997000 | 100.00 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -3777000 | -4747000 | 20.43 |
| cash at end of period | 13198000 | 4444000 | 196.98 |
| accounts receivables | 0 | -1483000 | 100.00 |
| cash at beginning of period | 4444000 | 9233000 | -51.87 |
Net Change in Cash: Net Change in Cash increased to 9 million in 2023 from -5 million in 2022 representing a change of 282.79%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 17 million in 2023 from 4 million in 2022 representing a change of 324.91%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 13 million in 2023 from 1 million in 2022 representing a change of 2240.15%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -4 million in 2023 from -3 million in 2022 representing a change of -26.15%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2023 from 2 million in 2022 representing a change of -4.42%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from 0 million in 2022 representing a change of 83.72%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2023 from 1 million in 2022 representing a change of 34.99%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to 0 in 2023 from -1 million in 2022 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000814586 | |||
| operating cash flow | 7451000 | 6544000 | 13.86 |
| free cash flow | 5911000 | 5108000 | 15.72 |
| capital expenditure | -1540000 | -1436000 | -7.24 |
| depreciation and amortization | 855000 | 836000 | 2.27 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 602000 | 623000 | -3.37 |
| accounts receivables | 831000 | 736000 | 12.91 |
| accounts payables | 1523000 | -568000 | 368.13 |
| inventory | 13000 | -324000 | 104.01 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -1540000 | -1436000 | -7.24 |
| net cash used for investing activites | -1526000 | -1436000 | -6.27 |
| debt repayment | 0 | -2500000 | 100.00 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 0 | -2500000 | 100.00 |
| net change in cash | 5925000 | 2608000 | 127.19 |
| cash at end of period | 20558000 | 14633000 | 40.49 |
| cash at beginning of period | 14633000 | 12025000 | 21.69 |
Net Change in Cash: Net Change in Cash increased to 6 million in 2024Q3 from 3 million in 2024Q2 representing a change of 127.19%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 7 million in 2024Q3 from 7 million in 2024Q2 representing a change of 13.86%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 6 million in 2024Q3 from 5 million in 2024Q2 representing a change of 15.72%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -2 million in 2024Q3 from -1 million in 2024Q2 representing a change of -7.24%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of -3.37%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 2 million in 2024Q3 from 1 million in 2024Q2 representing a change of 368.13%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 1 in 2024Q3 from 1 million in 2024Q2 representing a change of 12.91%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 10.92 | 9.2 | 18.73 |
| net income per share | 0.78 | 0.06 | 1191.34 |
| operating cash flow per share | 1.16 | 0.26 | 346.03 |
| free cash flow per share | 0.86 | 0.03 | 2356.46 |
| cash per share | 0.9 | 0.29 | 211.75 |
| book value per share | 4.12 | 3.09 | 33.36 |
| tangible book value per share | 2.85 | 1.85 | 54.47 |
| shareholders equity per share | 4.12 | 3.09 | 33.36 |
| interest debt per share | 0.23 | 0.45 | -49.99 |
| market cap | 196684470 | 85447800 | 130.18 |
| enterprise value | 186411470 | 87681800 | 112.60 |
| pe ratio | 17.3 | 92.48 | -81.29 |
| price to sales ratio | 1.23 | 0.6 | 103.51 |
| pocfratio | 11.61 | 21.43 | -45.83 |
| pfcf ratio | 15.62 | 158.82 | -90.16 |
| pb ratio | 3.25 | 1.8 | 81.18 |
| ptb ratio | 3.25 | 1.8 | 81.18 |
| ev to sales | 1.16 | 0.62 | 87.96 |
| enterprise value over ebitda | 9.23 | 17.26 | -46.52 |
| ev to operating cash flow | 11.0 | 21.99 | -49.97 |
| ev to free cash flow | 14.81 | 162.98 | -90.92 |
| earnings yield | 0.06 | 0.01 | 434.45 |
| free cash flow yield | 0.06 | 0.01 | 916.66 |
| debt to equity | 0.05 | 0.14 | -65.52 |
| debt to assets | 0.04 | 0.1 | -62.99 |
| net debt to ebitda | -0.51 | 0.44 | -215.67 |
| current ratio | 2.3 | 2.07 | 11.13 |
| interest coverage | 44.26 | 8.8 | 403.06 |
| income quality | 1.49 | 4.31 | -65.46 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.08 | 0.09 | -7.82 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.23 | 0.28 | -17.88 |
| capex to operating cash flow | 0.26 | 0.87 | -70.31 |
| capex to revenue | 0.03 | 0.02 | 11.53 |
| capex to depreciation | 1.38 | 1.16 | 18.57 |
| stock based compensation to revenue | 0.01 | 0.01 | 19.34 |
| graham number | 8.48 | 2.04 | 314.99 |
| roic | 0.17 | 0.02 | 749.45 |
| return on tangible assets | 0.18 | 0.02 | 872.75 |
| graham net net | 0.47 | -0.23 | 303.67 |
| working capital | 21580000 | 13936000 | 54.85 |
| tangible asset value | 41834000 | 28428000 | 47.16 |
| net current asset value | 16978000 | 5549000 | 205.97 |
| invested capital | 63138000 | 54157000 | 16.58 |
| average receivables | 12666500 | 10866000 | 16.57 |
| average payables | 8977500 | 7296500 | 23.04 |
| average inventory | 9367500 | 8958000 | 4.57 |
| days sales outstanding | 31.63 | 29.54 | 7.06 |
| days payables outstanding | 30.94 | 25.37 | 21.95 |
| days of inventory on hand | 28.24 | 30.63 | -7.80 |
| receivables turnover | 11.54 | 12.36 | -6.60 |
| payables turnover | 11.8 | 14.39 | -18.00 |
| inventory turnover | 12.93 | 11.92 | 8.46 |
| roe | 0.19 | 0.02 | 868.30 |
| capex per share | 0.3 | 0.22 | 32.42 |
ROE: Return on Equity (ROE) increased to 0.19 on 2023-12-31 from 0.02 on 2022-12-31, representing a change of 868.30%. Suggesting the company has been generating high returns for its shareholders.
Current Ratio: Current Ratio increased to 2.30 on 2023-12-31 from 2.07 on 2022-12-31, representing a change of 11.13%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2023-12-31 from 0.14 on 2022-12-31, representing a change of -65.52%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 17.30 on 2023-12-31 from 92.48 on 2022-12-31, representing a change of -81.29%. Indicating a decrease in the relative valuation of the company's stock.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| LWAY | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 3.11 | 3.34 | -6.70 |
| net income per share | 0.2 | 0.26 | -21.73 |
| operating cash flow per share | 0.5 | 0.44 | 13.29 |
| free cash flow per share | 0.4 | 0.35 | 15.14 |
| cash per share | 1.39 | 0.99 | 39.79 |
| book value per share | 4.83 | 4.62 | 4.66 |
| tangible book value per share | 3.6 | 3.37 | 6.83 |
| shareholders equity per share | 4.83 | 4.62 | 4.66 |
| interest debt per share | 0.01 | 0.01 | -30.70 |
| market cap | 383641920 | 181142100 | 111.79 |
| enterprise value | 363219920 | 166663100 | 117.94 |
| pe ratio | 32.23 | 11.97 | 169.22 |
| price to sales ratio | 8.32 | 3.68 | 125.86 |
| pocfratio | 51.49 | 27.68 | 86.01 |
| pfcf ratio | 64.9 | 35.46 | 83.02 |
| pb ratio | 5.36 | 2.66 | 101.35 |
| ptb ratio | 5.36 | 2.66 | 101.35 |
| ev to sales | 7.88 | 3.39 | 132.41 |
| enterprise value over ebitda | 70.05 | 26.7 | 162.36 |
| ev to operating cash flow | 48.75 | 25.47 | 91.41 |
| ev to free cash flow | 61.45 | 32.63 | 88.33 |
| earnings yield | 0.01 | 0.02 | -62.86 |
| free cash flow yield | 0.02 | 0.03 | -45.36 |
| debt to equity | 0.0 | 0.0 | -16.04 |
| debt to assets | 0.0 | 0.0 | -17.85 |
| net debt to ebitda | -3.94 | -2.32 | -69.80 |
| current ratio | 2.68 | 2.83 | -5.47 |
| interest coverage | 1047.25 | 114.6 | 813.86 |
| income quality | 2.5 | 1.73 | 44.74 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.08 | 0.08 | -9.01 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.2 | 0.22 | -7.66 |
| capex to operating cash flow | 0.21 | 0.22 | -5.81 |
| capex to revenue | 0.03 | 0.03 | 14.37 |
| capex to depreciation | 1.8 | 1.72 | 4.86 |
| stock based compensation to revenue | 0.01 | 0.01 | 3.05 |
| graham number | 4.68 | 5.17 | -9.49 |
| roic | 0.04 | 0.05 | -27.77 |
| return on tangible assets | 0.04 | 0.06 | -28.33 |
| graham net net | 1.02 | 0.88 | 16.18 |
| working capital | 28060000 | 25424000 | 10.37 |
| tangible asset value | 53326000 | 49665000 | 7.37 |
| net current asset value | 24980000 | 22335000 | 11.84 |
| invested capital | 72703000 | 69186000 | 5.08 |
| average receivables | 14100500 | 15074000 | -6.46 |
| average payables | 10243500 | 9697000 | 5.64 |
| average inventory | 8447500 | 8292000 | 1.88 |
| days sales outstanding | 26.35 | 26.92 | -2.14 |
| days payables outstanding | 29.23 | 23.41 | 24.85 |
| days of inventory on hand | 22.19 | 21.13 | 5.06 |
| receivables turnover | 3.42 | 3.34 | 2.19 |
| payables turnover | 3.08 | 3.84 | -19.90 |
| inventory turnover | 4.05 | 4.26 | -4.82 |
| roe | 0.04 | 0.06 | -25.21 |
| capex per share | 0.1 | 0.1 | 6.71 |
ROE: Return on Equity (ROE) decreased to 0.04 on 2024-09-30 Q3 from 0.06 on 2024-06-30 Q2, representing a change of -25.21%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 32.23 on 2024-09-30 Q3 from 11.97 on 2024-06-30 Q2, representing a change of 169.22%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of -16.04%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Current Ratio: Current Ratio decreased to 2.68 on 2024-09-30 Q3 from 2.83 on 2024-06-30 Q2, representing a change of -5.47%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Negative Sentiment: Discounted Cash Flow value is 11.66 which is lower than current price 22.45, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Negative
Publish Date: 2025-01-06 09:48:00
Company also announces unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million Full year 2024 preliminary unaudited net sales are projected to range between $185.0 million and $186.5 million compared to $160.1 million in 2023 MORTON GROVE, Ill. , Jan. 6, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has responded to the December 30, 2024 letter sent to Lifeway by Danone North America PBC ("Danone") reaffirming that the Company rejected Danone's offer to acquire the Company because it severely undervalues the Company, based on analysis by the Company's independent financial and legal advisors.
Sentiment: Negative
Publish Date: 2024-12-11 11:10:00
MORTON GROVE, Ill. , Dec. 11, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. manufacturer of kefir and fermented probiotic products, announced the distribution of its ProBugs Organic Kefir for kids at more than 250 Harris Teeter retail stores.
Sentiment: Positive
Publish Date: 2024-12-08 12:20:50
Lifeway Foods has rejected not one, but two takeover offers from Danone, but the kefir and fermented probiotic food products company remains "in play." The latest in an ongoing saga amongst the company's founding family may prove key in driving the company into the hands of this would-be strategic acquirer. More importantly for new and existing LWAY shareholders, this could result in Danone ultimately paying as much as $35 per share for the company.
Sentiment: Negative
Publish Date: 2024-11-26 07:30:00
MORTON GROVE, Ill. , Nov. 26, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
Sentiment: Positive
Publish Date: 2024-11-22 09:45:00
CHICAGO , Nov. 22, 2024 /PRNewswire/ -- Edward and Ludmila Smolyansky ("Founding Shareholders"), who together exercise voting control with respect to approximately 29.7% of the outstanding shares of common stock of Lifeway Foods, Inc. (NASDAQ: LWAY), today called for Lifeway's board of directors to take several actions, including immediately establishing an independent special committee to evaluate and negotiate a transaction with Danone or other potential buyers. This follows a proposal by Danone North America PBC to acquire all outstanding shares of Lifeway that Danone does not already own for $27 per share in cash.
Sentiment: Positive
Publish Date: 2024-11-20 09:15:00
Leading U.S. Kefir Brand Announces Functional Beverage Made with Kefir Cultures to Support Skin Health, Immune System and the Microbiome MORTON GROVE, Ill. , Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, has announced its latest functional beverage innovation: Probiotic Smoothie + Collagen made with kefir cultures.
Sentiment: Negative
Publish Date: 2024-11-20 07:30:00
MORTON GROVE, Ill. , Nov. 20, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors has rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
Sentiment: Positive
Publish Date: 2024-11-18 11:30:55
LWAY continues its impressive growth streak, marking 20 consecutive quarters of rising sales.
Sentiment: Positive
Publish Date: 2024-11-15 16:33:00
MORTON GROVE, Ill. , Nov. 15, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America PBC ("Danone") to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash.
Sentiment: Positive
Publish Date: 2024-11-14 13:09:09
Lifeway Foods, Inc. (NASDAQ:LWAY ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Julie Smolyansky - President and Chief Executive Officer Conference Call Participants Operator Good morning. Welcome to Lifeway Foods' Third Quarter 2024 Conference Call.
Sentiment: Positive
Publish Date: 2024-11-14 11:15:30
Lifeway Foods (LWAY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.23 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-14 09:00:00
Year-to-date net sales of $139.9 million; up 18.5% year-over-year Heightened interest in probiotic foods with bioavailable nutrients drives volume growth of Lifeway Kefir and Farmer Cheese 20th consecutive quarter of year-over-year growth Year-to-date gross profit margin increased to 26.2% MORTON GROVE, Ill. , Nov. 14, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2024.
Sentiment: Neutral
Publish Date: 2024-11-08 16:49:00
MORTON GROVE, Ill. , Nov. 8, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2024 on November 14, 2024 before market hours.
Sentiment: Negative
Publish Date: 2024-11-07 16:46:00
CHICAGO , Nov. 7, 2024 /PRNewswire/ -- On September 23, 2024, Danone SA (OTCQX: DANOY) proposed to acquire Lifeway Foods (NASDAQ: LWAY) in a transaction valued at approximately $283 million, offering $25 per share in cash. However, on November 6, the Lifeway Foods Board of Directors rejected the offer, instead adopting a "poison pill" limited shareholder rights plan.
Sentiment: Positive
Publish Date: 2024-11-07 10:41:00
Lifeway CEO Julie Smolyansky announces substantial new distribution during Gulfood Manufacturing exhibition DUBAI, UAE, Nov. 7, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), a leading U.S. manufacturer of kefir and fermented probiotic products, announced today an expanded distribution agreement in the United Arab Emirates market. The offering of 32oz Lifeway Kefir, 8oz Lactose-Free Lifeway Kefir, ProBugs and farmer cheese, exported from the United States, is expected to begin shipping in the fourth quarter of 2024 and will become available in supermarkets and hypermarkets in Dubai and across the Emirates.
Sentiment: Negative
Publish Date: 2024-11-05 09:00:00
MORTON GROVE, Ill. , Nov. 5, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has rejected the unsolicited proposal made on September 23, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $25.00 per share.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
